• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏脂肪面积和静息能量消耗在肥胖和非酒精性脂肪肝瘦患者代谢特征评估中的价值。

Value of Visceral Fat Area and Resting Energy Expenditure in Assessment of Metabolic Characteristics in Obese and Lean Nonalcoholic Fatty Liver Disease.

机构信息

Department of Gastroenterology and Hepatology, The Third Central Hospital of Tianjin, Tianjin, China;Tianjin Institute of Hepatobiliary Disease, Tianjin, China;Artificial Cell Engineering Technology Research Center, Tianjin, China;The Third Central Clinical College of Tianjin Medical University, Tianjin, China.

The Third Central Clinical College of Tianjin Medical University, Tianjin, China;Nutritional Department, The Third Central Hospital of Tianjin, Tianjin, China.

出版信息

Turk J Gastroenterol. 2021 Feb;32(2):116-122. doi: 10.5152/tjg.2021.20908.

DOI:10.5152/tjg.2021.20908
PMID:33960934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8975487/
Abstract

BACKGROUND

The high prevalence and incidence of non-alcoholic fatty liver disease (NAFLD) have become a global medical concern. Compared with obesity, metabolic abnormalities may be more critical. Currently, there is lack of relevant data for nutritional status and energy metabolic characteristics in patients with obese and lean NAFLD.

METHODS

All the enrolled NAFLD patients were divided into 2 groups: the obese group (205 patients with body mass index (BMI) ≥ 25 kg/m2) and the lean group (73 patients with BMI < 25 kg/m2). Using a body composition analyzer, we analyzed their nutritional status including skeletal muscle, body fat, protein content, and visceral fat area (VFA). Energy metabolic characteristics including resting energy expenditure (REE), respiratory quotient, and oxidation rate of 3 major nutrients (carbohydrate, CHO%, fat, FAT%, and protein, PRO%) were analyzed by metabolic cart.

RESULTS

The lean NAFLD patients' LDL-c and UA even increased significantly than the obese patients (P = .001 and .006, respectively). Compared with the control group, VFA and REE were significantly higher in the lean NAFLD group (P = .008, P < .001 respectively). CHO%, FAT%, and PRO% in the lean NAFLD group were 29.31 ± 7.07%, 55.59 ± 12.09%, and 15.10 ± 4.07%, respectively, and there was no significant difference compared to the control. However, compared to the obese NAFLD group, their CHO% increased, whereas FAT% decreased (both P < .001).

CONCLUSION

NAFLD patients suffer from nutritional imbalances and energy metabolic abnormalities, regardless of whether they are associated with obesity. LDL, UA, VFA, and REE can be used as good evaluation indicators.

摘要

背景

非酒精性脂肪性肝病(NAFLD)的高患病率和发病率已成为全球关注的医学问题。与肥胖相比,代谢异常可能更为关键。目前,尚缺乏肥胖和非肥胖 NAFLD 患者营养状况和能量代谢特征的相关数据。

方法

所有入组的 NAFLD 患者分为两组:肥胖组(205 例 BMI≥25kg/m2)和非肥胖组(73 例 BMI<25kg/m2)。采用人体成分分析仪分析其骨骼肌、体脂、蛋白质含量和内脏脂肪面积(VFA)等营养状况。采用代谢车分析静息能量消耗(REE)、呼吸商和三大营养素(碳水化合物,CHO%;脂肪,FAT%;蛋白质,PRO%)氧化率的能量代谢特征。

结果

与肥胖组相比,非肥胖 NAFLD 患者的 LDL-c 和 UA 甚至更高(P=0.001 和 P=0.006)。与对照组相比,非肥胖 NAFLD 组的 VFA 和 REE 明显更高(P=0.008,P<0.001)。非肥胖 NAFLD 组的 CHO%、FAT%和 PRO%分别为 29.31±7.07%、55.59±12.09%和 15.10±4.07%,与对照组无显著差异。然而,与肥胖 NAFLD 组相比,CHO%升高,FAT%降低(均 P<0.001)。

结论

NAFLD 患者存在营养失衡和能量代谢异常,无论是否伴有肥胖。LDL、UA、VFA 和 REE 可作为较好的评价指标。

相似文献

1
Value of Visceral Fat Area and Resting Energy Expenditure in Assessment of Metabolic Characteristics in Obese and Lean Nonalcoholic Fatty Liver Disease.内脏脂肪面积和静息能量消耗在肥胖和非酒精性脂肪肝瘦患者代谢特征评估中的价值。
Turk J Gastroenterol. 2021 Feb;32(2):116-122. doi: 10.5152/tjg.2021.20908.
2
[Nutritional status and energy metabolism characteristics in patients with nonalcoholic fatty liver disease].非酒精性脂肪性肝病患者的营养状况与能量代谢特征
Zhonghua Gan Zang Bing Za Zhi. 2018 Jul 20;26(7):524-529. doi: 10.3760/cma.j.issn.1007-3418.2018.07.009.
3
Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.全身底物代谢与非酒精性脂肪性肝病患者的疾病严重程度相关。
Gut. 2013 Nov;62(11):1625-33. doi: 10.1136/gutjnl-2012-302789. Epub 2012 Oct 17.
4
The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.中国 2 型糖尿病患者肌少症和内脏型肥胖与非酒精性脂肪肝瘦体组织含量的关系。
J Diabetes Res. 2022 Nov 4;2022:2229139. doi: 10.1155/2022/2229139. eCollection 2022.
5
Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.瘦型非酒精性脂肪性肝病(NAFLD)患者的临床特征和代谢特征及其与肥胖和超重 NAFLD 的比较。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
6
Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.非酒精性脂肪性肝病患者的肥胖与非肥胖患者的生活方式预测因素:一项横断面研究。
Clin Nutr. 2018 Oct;37(5):1550-1557. doi: 10.1016/j.clnu.2017.08.018. Epub 2017 Aug 30.
7
[Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].[中山地区不同体重非酒精性脂肪性肝病患者的脂质代谢]
Ter Arkh. 2023 Jan 16;94(12):1361-1366. doi: 10.26442/00403660.2022.12.201998.
8
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
9
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
10
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.瘦型非酒精性脂肪性肝病增加了正常体重中国人群发生代谢紊乱的风险。
World J Gastroenterol. 2014 Dec 21;20(47):17932-40. doi: 10.3748/wjg.v20.i47.17932.

本文引用的文献

1
Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?代谢相关脂肪性肝病:是时候将开创性的新术语融入我们的临床实践了吗?
Hepatol Forum. 2020 Sep 21;1(3):79-81. doi: 10.14744/hf.2020.2020.0024. eCollection 2020 Sep.
2
The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patients.经活检证实的非酒精性脂肪性肝炎患者与非酒精性脂肪肝患者静息代谢率的比较。
Hepatol Forum. 2020 Jan 17;1(1):14-19. doi: 10.14744/hf.2020.0004. eCollection 2020 Jan.
3
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
4
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义:国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
5
Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients.强化饮食和生活方式干预在瘦型非酒精性脂肪性肝病患者治疗中的作用。
Eur J Gastroenterol Hepatol. 2020 Oct;32(10):1352-1357. doi: 10.1097/MEG.0000000000001656.
6
Non-Alcoholic Fatty Liver Disease is Associated with Higher Metabolic Expenditure in Overweight and Obese Subjects: A Case-Control Study.非酒精性脂肪性肝病与超重和肥胖受试者更高的代谢消耗有关:一项病例对照研究。
Nutrients. 2019 Aug 7;11(8):1830. doi: 10.3390/nu11081830.
7
Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.土耳其非酒精性脂肪性肝病负担日益加重:单中心经验
Turk J Gastroenterol. 2019 Oct;30(10):892-898. doi: 10.5152/tjg.2019.19072.
8
Non-alcoholic fatty liver disease: A growing public health problem in Turkey.非酒精性脂肪性肝病:土耳其日益严重的公共卫生问题。
Turk J Gastroenterol. 2019 Oct;30(10):865-871. doi: 10.5152/tjg.2019.18045.
9
Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis.2008 年至 2018 年中国非酒精性脂肪性肝病负担的意外快速增长:系统评价和荟萃分析。
Hepatology. 2019 Oct;70(4):1119-1133. doi: 10.1002/hep.30702.
10
Nonalcoholic Fatty Liver Disease and Obesity Treatment.非酒精性脂肪性肝病与肥胖症治疗。
Curr Obes Rep. 2019 Sep;8(3):220-228. doi: 10.1007/s13679-019-00345-1.